This is reminiscent of the recent work demonstrating the importance of elevated HER2 levels in non-amplified HER2 breast cancer stem cells [27] and suggests that HER2 may be playing a role in the early stages of cancer development, setting the stage for future oncogenic events. The gene discussed is ERBB2; the disease is breast cancer.